Approval · Notice of Compliance 25949 · 2021
PRINIVIL: Notice of Compliance 25949
Issued May 28, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25949
- Date
- May 28, 2021
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the safety information in the Drug-Drug interaction section of the Product Monograph, and to update the Product Monograph to the Master Template forma
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRINIVIL | Not yet assigned | — |
Medicinal ingredients
- LISINOPRIL 10 MG per TAB
- LISINOPRIL 20 MG per TAB